Pelthos Therapeutics (PTHS) Revenue (2025 - 2026)

Pelthos Therapeutics has reported Revenue for 2 years, with the latest figure at $26.5 million in Q2 2026.

• On a quarterly basis, Revenue changed N/A year-over-year to $26.5 million in Q2 2026; TTM through Jun 2026 was $53.9 million, a N/A change from a year earlier, with the FY2026 full-year figure at $42.3 million, changed N/A from the prior year.
• Revenue was $26.5 million for Q2 2026 at Pelthos Therapeutics, up from $10.9 million in the prior quarter.
• The five-year high for Revenue was $26.5 million in Q2 2026, with the low at $7.4 million in Q3 2025.